Accessibility Menu
InterCure logo

InterCure

(NASDAQ) INCR

Current Price$1.02
Market Cap$55.77M
Since IPO (2019)-59%
5 Year-88%
1 Year-31%
1 Month+16%

InterCure Financials at a Glance

Market Cap

$55.77M

Revenue (TTM)

₪243.12M

Net Income (TTM)

-₪70.93M

EPS (TTM)

-$0.20

P/E Ratio

-5.10

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$1.02

Volume

21,401

Open

$1.05

Previous Close

$1.02

Daily Range

$0.99 - $1.05

52-Week Range

$0.68 - $1.77

Estimated Earnings Date

Apr 29, 2026

INCR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InterCure

Industry

Pharmaceuticals

Employees

285

CEO

Alexander Rabinovitch

Headquarters

Herzliya, 4676670, IL

INCR Financials

Key Financial Metrics (TTM)

Gross Margin

22%

Operating Margin

-18%

Net Income Margin

-19%

Return on Equity

0%

Return on Capital

-7%

Return on Assets

-5%

Earnings Yield

-19.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$55.77M

Shares Outstanding

54.68M

Volume

21.40K

Avg. Volume

33.02K

Financials (TTM)

Gross Profit

₪33.18M

Operating Income

₪6.73M

EBITDA

-₪7.29M

Operating Cash Flow

₪16.84M

Capital Expenditure

-₪3.55M

Free Cash Flow

₪13.29M

Cash & ST Invst.

₪46.68M

Total Debt

₪183.01M

InterCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

₪65.01M

+3.4%

Gross Profit

₪20.11M

-3.4%

Gross Margin

30.94%

N/A

Market Cap

$55.77M

N/A

Market Cap/Employee

$174.30K

N/A

Employees

320

N/A

Net Income

-₪852.00K

-218.9%

EBITDA

₪7.13M

-1.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

-₪136.34M

-2.7%

Accounts Receivable

₪154.47M

+194.5%

Inventory

₪108.06M

-10.2%

Long Term Debt

₪78.95M

-42.4%

Short Term Debt

₪104.06M

+40.2%

Return on Assets

-5.26%

N/A

Return on Invested Capital

-6.96%

N/A

Free Cash Flow

₪4.48M

N/A

Operating Cash Flow

₪6.10M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BMEABiomea Fusion, Inc.
$1.27-7.30%
HYFTMindWalk Holdings Corp.
$1.68-9.19%
CAMPCAMP4 Therapeutics Corporation
$4.11-4.42%
FBIOFortress Biotech, Inc.
$2.65-4.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%
IBITiShares Bitcoin Trust
$34.14-0.05%

Questions About INCR

What is the current price of InterCure?

InterCure is trading at $1.02 per share.

What is the 52-week range for InterCure?

Over the past 52 weeks, InterCure has traded between $0.68 and $1.77.

How much debt does InterCure have?

As of the most recent reporting period, InterCure reported total debt of ₪57.42M.

How much cash does InterCure have on hand?

InterCure reported ₪15.22M in cash and cash equivalents in its most recent financial results.

What is InterCure’s dividend yield?

InterCure does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.